The Perrigo has received approval from the FDA to market over-the-counter coated nicotine polacrilex lozenge USP, 2mg and 4mg in cherry and cinnamon flavors.
The company said that the new products will be marketed under store brand labels and are comparable to GlaxoSmithKline’s Commit lozenge, which is an aid to smoking cessation.
Joseph Papa, chairman and CEO of Perrigo, said: These two approvals expand our exclusive position in the store brand nicotine lozenge category. The expanded range of smoking cessation products also includes coated mint and Fruit Chill flavored gum, uncoated gum and lozenges.
Perrigo develops, manufactures and distributes OTC and generic prescription pharmaceuticals, nutritional products, active pharmaceutical ingredients and consumer products.